Novartis | Ventes



Sales Changement Date
AbbVie USD 13.34B 1.76B 2025-03
Amgen USD 8.15B 936M 2025-03
AstraZeneca USD 13.59B 1.3B 2025-03
Bausch Health Companies USD 2.26B 300M 2025-03
Biogen USD 2.43B 24.7M 2025-03
Bristol-Myers Squibb USD 11.2B 1.14B 2025-03
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 157.2M 24.69M 2025-03
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 12.73B 802.8M 2025-03
Gilead Sciences USD 6.67B 899M 2025-03
GlaxoSmithKline GBP 7.52B 600M 2025-03
Glaxosmithkline GBP 8.12B 105M 2024-12
Indivior 266M 32M 2025-03
J&J USD 21.89B 630M 2025-03
Merck USD 15.53B 94M 2025-03
Novartis USD 13.15B 330M 2024-12
Novartis USD 13.56B 386M 2024-12
Pacira USD 168.92M 18.33M 2025-03
Perrigo USD 1.04B 98.3M 2025-03
Pfizer USD 13.72B 4.04B 2025-03
Prestige Brands USD 296.52M 6.2M 2025-03
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 9.9B 660M 2025-03
Sanofi EUR 11.26B 3.5B 2024-12
Supernus Pharmaceuticals USD 149.8M 24.36M 2025-03
Zoetis USD 2.22B 97M 2025-03



Novartis Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.